Abstract
Insulin stimulated phosphorylation of tyrosine residues by the insulin receptor kinase may be part of a signalling mechanism associated with insulin's action. We report that indomethacin inhibited the phosphorylation of the β-subunit of the solubilized adipocyte insulin receptor. Indomethacin also inhibited several insulin-sensitive processes in intact rat adipocytes. Indomethacin (1 mM) inhibited basal phosphorylation of the β-subunit of the solubilized insulin receptor by 6007o and insulin-stimulated phosphorylation by 30%. In adipocytes, indomethacin inhibited basal 3-0-[methyl-14C]-methyl-D glucose transport by 50070 (P < 0.01), D-[6-14C]-glucose oxidation by 5007o (P < 0.01), D-[6-14C]-glucose conversion to lipid by 30010 (P < 0.01), and D-[1-14C]-glucose conversion to lipid by 6007o (P<0.01). Similarly, indomethacin inhibited insulin-stimulated 3-0-[methyl-14C]-methyl-D-glucose transport by 75070 (P<0.01), D-[6-14C]-glucose oxidation by 20% (P<0.05), D-[1-14C]-glucose oxidation by 35070 (P<0.01), D-[6-14C] glucose conversion to lipid by 25010 (P<0.01), and D-[1-14C] glucose conversion to lipid by 4501o (P<0.01). In contrast, insulin binding to its receptor, basal D-[1-14C]-glucose oxidation and both basal and insulin-stimulated activation of glycogen synthase were unaffected by indomethacin. Thus, indomethacin partially inhibited autophosphorylation of the solubilized insulin receptor on tyrosine and partially inhibited some but not all of insulin's actions. This supports the hypothesis that insulin's metabolic effects are linked to activation of the insulin receptor protein kinase and indicates that there may be heterogeneity in the mechanisms of intracellular metabolic control by insulin.
Similar content being viewed by others
References
Kasuga M, Karlsson FA, Kahn CR: Insulin stimulation of the phosphorylation of the 95 000-dalton subunit of its own receptor. Science 215:185–187, 1982.
Kasuga M, Zick Y, Blithe DL, Crettaz M, Kahn CR: Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature 293:667–669, 1982.
Kasuga M, Fujita-Yamaguchi Y, Blithe DL, Kahn CR: Tyrosine-specific protein kinase activity is associated with the purified insulin receptor. Proc Natl Acad Sci (USA) 80:2137–2141, 1983.
Haring H, Kasuga M, Kahn CR: Insulin receptor phosphorylation in intact adipocytes and in a cell free system. BBRC 108:1538–1545.
Tamura S, Brown TA, Dubler RE, Larner J: Insulin-like effect of vanadate on adipocyte glycogen synthase and on phosphorylation of 95 000 dalton subunit of insulin receptor. Biochem Biophys Res Commun 113:80–86, 1983.
Avruch J, Nemenoff RA, Blackshear PJ, Pierce MW, Osatharondh R: Insulin-stimulated tyrosine phosphorylation of the insulin receptor in detergent extracts of human placental membranes. J Biol Chem 257:15162–15166.
Petruzelli LM, Ganguly S, Smith CJ, Cobb MH, Rubin CH, Rosen OM: Insulin activates a tyrosine-specific protein kinase in extracts of 3T3-L1 adipocytes and human placenta. Proc Natl Acad Sci (USA) 79:6792–6796, 1982.
Grunberger G, Comi RJ, TaylorSI, Gorden P: Tyrosine kinase activity of the insulin receptor of patients with type A extreme insulin resistance: studies with circulating mononuclear cells and cultured lymphocytes. J Clin Endo Metab 59:1152–1158, 1984.
Roth RA, Cassell DJ, Maddux BA, Goldfine ID: Regulation of insulin receptor kinase activity by insulin mimickers and an insulin antagonist. Biochem Biophys Res Commun 115:245, 1983.
Zick Y, Rees-Jones RW, Taylor SI, Gordon P, Roth J: The role of anti-receptor antibodies in stimulating phosphorylation of the insulin receptor. J Biol Chem 259:4396–4400, 1984.
Ahmet K, Goucli SA: Indomethacin and inhibition of protein kinase reaction. Nature 287:171–172, 1980.
Kantor HS, Hampton M: Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase. Nature 276:841–842, 1978.
Rodbell M: Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375–380, 1964.
El Allaway RMM, Gliemann J: Trypsin treatment of adipocytes: effect on sensitivity to insulin. Biochim Biophys Acta 273:97–109, 1972.
Dole VP: A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest 35:150–154, 1956.
Whitesell RR, Gliemann J: Kinetic parameters of transport of 3–0 methylglucose and glucose in adipocytes. J Biol Chem 254:5267–5283, 1979.
Guinovart JJ, Salvert A, Massague J, Ciudad CJ, Salsas E, Itarte E: Glycogen synthase: a new activity ratio expressing a high sensitivity to the phosphorylation state. FEBS Letters 106:284–288, 1979.
Tamura S, Brown TA, Whipple JH, Fujita-Yamaguchi Y, Dubler RE, Cheng K, Larner J: A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J Biol Chem 259:6650–6658, 1984.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature Lond 227:680–685, 1970.
King LE Jr, Carpenter G, Cohen S: Characterization by electrophoresis of epidermal growth factor stimulated phosphorylation using A-431 membranes. Biochemistry 19:1524–1528, 1980.
Cohen S, Carpenter G, King L Jr: Epidermal growth factor-receptor-protein kinase interactions. J Biol Chem 255:4834–4842, 1980.
Ushiro H, Cohen S: Identification of phosphotyrosine as a product of epidermal growth factors-activated protein kinase in A-431 cell membranes. J Biol Chem 255:8363–8365, 1980.
Erikson E, Shealy DJ, Erikson RL: Evidence that viral transforming gene products and epidermal growth factor stimulate phosphorylation of the same cellular protein with similar specificity. J Biol Chem 256:11381–11384, 1981.
Ek B, Westermark B, Wasteson A, Heldin C: Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor. Nature 295:419–420, 1982.
Rubin JB, Shia MA, Pilch PF: Stimulation of tyrosinespecific phosphorylation in vitro by insulin-like growth factor I. Nature 305:438–440, 1983.
Cheng K, Galasko G, Huang L, Kellogg J, Larner J: Studies on the insulin mediator. II. Separation of two antagonistic biologically active materials from fraction II. Diabetes 29:659–661, 1980.
Saltiel AR, Siegel MI, Jacobs S: Putative mediators of insulin action: regulation of pyruvate dehydrogenase and adenylate cyclase activities. Proc Natl Acad Sci (USA) 79:3513–3517, 1982.
Larner J: Insulin mediator — fact of fancy. J Cyc Nuc Res 8:289–296, 1982.
Jarett L, Wong EHA, Smith JA, McCaulay SL: Stimulation of pyruvate dehydrogenase activity in intact rat adipocytes by insulin mediator from rat skeletal muscle. Endocrinology 116(3):1011–1016, 1985.
Jarett L, Wong EHA, MaCaulay SL, Smith JA: Insulin mediators from rat skeletal muscle have differential effects on insulin-sensitive pathways of intact adipocytes. Science 227:535–553, 1985.
Londos C, Cooper DMF, Rodbell M: Receptor-mediated stimulation and inhibition of adenylate cyclases: the fat cell as a model system. Adv in Cyc Nuc Res 14:163–171, 1981.
Kashiwagi A, Hucksteadt P, Foley JE: The regulation of glucose transport by cAMP stimulates via three different mechanisms in rat and human adipocytes. J Biol Chem 258(22):13685–13691, 1983.
Lawrence JC, James C: Activation of glycogen synthase by insulin in rat adipocytes. J Biol Chem 259(12):7975–7982, 1984.
Helleburg L: Clinical pharmacokinetics of indomethacin. Clin Pharmacokinetics 6:245–258, 1982.
Chen M, Robertson RP: Effects of prostaglandin synthesis inhibitor on human insulin secretion and carbohydrate tolerance. Prostaglandin 18:557–567, 1979.
Newman WP, Brodows RG: Aspirin causes tissue insensitivity to insulin in normal man. J Clin Endo Metab 57:1102–1106, 1983.
Begum N, Tepperman HM, Tepperman J: Studies on the possible involvement of prostaglandins in insulin generation of pyruvate dehydrogenase activator. Diabetes 34:29–37, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malchoff, C.D., Messina, J.L., Gordon, V. et al. Inhibition of insulin receptor phosphorylation by indomethacin. Mol Cell Biochem 69, 83–90 (1985). https://doi.org/10.1007/BF00225930
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00225930